Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer.
Animals
Antineoplastic Agents
/ chemistry
HL-60 Cells
Histone Deacetylase Inhibitors
/ chemistry
Humans
K562 Cells
Mice
Mice, Inbred BALB C
Mice, Nude
Molybdoferredoxin
Neoplasm Proteins
/ antagonists & inhibitors
Neoplasms
/ drug therapy
Sirtuin 1
/ antagonists & inhibitors
Sirtuin 2
/ antagonists & inhibitors
U937 Cells
cancer
cell cycle
migration
sirtuins
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
12 Nov 2019
12 Nov 2019
Historique:
received:
30
09
2019
revised:
05
11
2019
accepted:
08
11
2019
entrez:
16
11
2019
pubmed:
16
11
2019
medline:
2
4
2020
Statut:
epublish
Résumé
Sirtuins, a family of nicotinamide adenine dinucleotide (NAD
Identifiants
pubmed: 31726691
pii: ijms20225654
doi: 10.3390/ijms20225654
pmc: PMC6888689
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Histone Deacetylase Inhibitors
0
Molybdoferredoxin
0
Neoplasm Proteins
0
SIRT1 protein, human
EC 3.5.1.-
SIRT2 protein, human
EC 3.5.1.-
Sirtuin 1
EC 3.5.1.-
Sirtuin 2
EC 3.5.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Università degli Studi della Campania "L.Vanvitelli"
ID : VALERE: Vanvitelli per la Ricerca Program
Organisme : EU- FP7-BLUEPRINT (282510)
ID : 282510
Organisme : MIUR
ID : PRIN-20152TE5PK
Organisme : Ministero della Salute
ID : PE-2013-02355271
Organisme : AIRC-
ID : 17217
Organisme : AIRC
ID : 19162
Organisme : Campania Regional Government Lotta alle Patologie Oncologiche, iCURE
ID : CUP B21c17000030007
Organisme : Campania Regional Government FASE 2: IDEAL
ID : CUP B63D18000560007
Organisme : Italian Ministry of Health
ID : GR-2018-12366268
Références
Nat Rev Cancer. 2006 Jan;6(1):38-51
pubmed: 16397526
Nat Rev Cancer. 2011 Sep 23;11(10):726-34
pubmed: 21941284
J Biol Chem. 2013 Apr 19;288(16):11004-12
pubmed: 23463510
Int J Dev Biol. 2009;53(2-3):303-22
pubmed: 19378253
J Biol Chem. 2002 Nov 22;277(47):45099-107
pubmed: 12297502
Int J Mol Sci. 2017 Jul 01;18(7):null
pubmed: 28671573
J Med Chem. 2016 Feb 25;59(4):1471-91
pubmed: 26689352
J Clin Invest. 2014 Jan;124(1):30-9
pubmed: 24382387
J Med Chem. 2012 Nov 26;55(22):9467-91
pubmed: 23030799
Annu Rev Pathol. 2010;5:253-95
pubmed: 20078221
Bioorg Med Chem Lett. 2019 Jan 1;29(1):78-82
pubmed: 30442421
J Med Chem. 2012 Dec 27;55(24):10937-47
pubmed: 23189967
Biofactors. 2012 Sep-Oct;38(5):349-59
pubmed: 22730114
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):E2772-81
pubmed: 23840057
Nat Rev Cancer. 2001 Dec;1(3):194-202
pubmed: 11902574
Clin Cancer Res. 2018 Jun 15;24(12):2886-2900
pubmed: 29535128
Oncogene. 2009 Feb 12;28(6):781-91
pubmed: 19060927
Front Pharmacol. 2012 Jan 31;3:4
pubmed: 22319497
PLoS One. 2013 Oct 09;8(10):e76899
pubmed: 24130806
Cell Death Dis. 2014 Oct 23;5:e1483
pubmed: 25341037
J Med Chem. 2005 Dec 15;48(25):8045-54
pubmed: 16335928
Genes Cancer. 2011 Jun;2(6):648-62
pubmed: 21941620
Front Pharmacol. 2019 Jan 30;10:38
pubmed: 30761005
Clin Epigenetics. 2016 May 25;8:61
pubmed: 27226812
Mol Cell. 2012 May 25;46(4):484-94
pubmed: 22542455
PLoS Genet. 2018 Jun 7;14(6):e1007362
pubmed: 29879107
Mol Cancer Ther. 2011 Dec;10(12):2394-404
pubmed: 21980132
Int J Biol Sci. 2016 Dec 6;12(12):1555-1567
pubmed: 27994519
Genes Cancer. 2013 Mar;4(3-4):148-63
pubmed: 24020006
Cancer Cell. 2008 May;13(5):454-63
pubmed: 18455128
Int J Biochem Cell Biol. 2009 Jan;41(1):199-213
pubmed: 18790076
Sci Rep. 2019 Mar 14;9(1):4490
pubmed: 30872694
Br J Cancer. 2014 Feb 4;110(3):656-67
pubmed: 24281001
Cancer Res. 2006 Apr 15;66(8):4368-77
pubmed: 16618762
Nutrients. 2018 Jun 06;10(6):null
pubmed: 29882797
J Med Chem. 2009 Sep 10;52(17):5496-504
pubmed: 19663498
Trends Pharmacol Sci. 2017 May;38(5):459-472
pubmed: 28389129
Oncol Rep. 2016 Jan;35(1):235-42
pubmed: 26530275